ELMI was created in 2001 to establish a unique communication network between European scientists working in the field of light microscopy and the manufacturers of their equipment.
Thanks to Danish Bioimaging Network (https://www.danishbioimaging.dk/) we can now can offer 2 conference grants to cover participation fees and hotel accommodation (equal to 5015dkk) in our conference Biological and pharmaceutical applications of CRS microscopy for 2 young researchers at a PhD and postdoc level.
The conference will take place in Odense, Denmark, 2-4 of December 2019.
To apply for the grant, please send:
to vita(at)sdu.dk before the 15th of September 2019.
The main focus of the conference will be on pharmaceutical and life science orientated applications such as drug delivery, cancer diagnostics, cell and tissue imaging. However, topics such as biomedical, food, and materials science will also be covered and are welcome.
Confirmed speakers is at present:
Andreas Zumbusch, Universität Konstanz, Germany (Keynote speaker)
Natalie Belsey, National Physical Laboratory, UK
Val Brunton, The University of Edinburgh, UK
Richard Guy, University of Bath, UK
Oleksii Ilchenko, Technical University of Denmark, Denmark
Minbiao Ji, Fudan University, Shanghai, China
Hakan Keles, GSK Medicines Research Centre, London, UK
Volker Schweikhard, Leica Microsystems, Mannheim, Germany
Clare Strachan, University of Helsinki, Finland
The overarching goal of the conference is to bring together the CRS microscopy community to facilitate exchange of knowledge between users and instrument developers. It is thus our hope that in this meeting we can share experience, knowledge and develop new imaging strategies helping to bridge the gap between instrument development and applications. Bringing together this community of students, scientists, and engineers to share the most recent insights and applications of CRS microscopy – from the perspective of their respective disciplines – will allow the sharing of new knowledge, mutual learning, and the opportunity to develop new collaborations.